BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18538450)

  • 1. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.
    Kini SG; Bhat AR; Bryant B; Williamson JS; Dayan FE
    Eur J Med Chem; 2009 Feb; 44(2):492-500. PubMed ID: 18538450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli.
    Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A
    Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
    Bonde CG; Peepliwal A; Gaikwad NJ
    Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
    Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel antitubercular compounds through hybrid virtual screening approach.
    Muddassar M; Jang JW; Hong SK; Cho YS; Kim EE; Keum KC; Oh T; Cho SN; Pae AN
    Bioorg Med Chem; 2010 Sep; 18(18):6914-21. PubMed ID: 20727773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
    Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
    IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
    Nayyar A; Monga V; Malde A; Coutinho E; Jain R
    Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
    Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of novel molecules with a diphenyl ether nucleus as potential antitubercular agents.
    Yang Y; Wang Z; Yang J; Yang T; Pi W; Ang W; Lin Y; Liu Y; Li Z; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):954-7. PubMed ID: 22197389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
    Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of InhA inhibitors in the class of diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulations.
    Kamsri P; Koohatammakun N; Srisupan A; Meewong P; Punkvang A; Saparpakorn P; Hannongbua S; Wolschann P; Prueksaaroon S; Leartsakulpanich U; Pungpo P
    SAR QSAR Environ Res; 2014; 25(6):473-88. PubMed ID: 24785640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
    Stigliani JL; Arnaud P; Delaine T; Bernardes-GĂ©nisson V; Meunier B; Bernadou J
    J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
    Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
    Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
    Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
    ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.